Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard APO vs Consolidation with Vinblastine in Advanced ALCL
NCT00059839Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Nov 2003
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised trial of vinblastine in anaplastic large cell lymphoma (ALCL) (2 arms), sponsored by Children's Oncology Group. Primary endpoint: Event-free Survival at 3 years. Started Nov 2003; status: completed.
02
Drugs
vinblastine
03
Conditions
anaplastic large cell lymphoma (ALCL)
Beyond the preview
Go deeper on NCT00059839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059839.